The electrocardiograph (ecg) market size has grown strongly in recent years. It will grow from $9.48 billion in 2025 to $10.36 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, expansion of hospital diagnostic infrastructure, increasing use of non-invasive diagnostic tools, growth in cardiac screening programs, availability of compact ecg systems.
The electrocardiograph (ecg) market size is expected to see strong growth in the next few years. It will grow to $14.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing adoption of home-based cardiac monitoring, rising integration of ai-based ecg analysis, growing demand for continuous patient monitoring, expansion of telecardiology services, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of portable and wearable ecg devices, rising integration of wireless ecg monitoring systems, growing use of remote cardiac monitoring solutions, expansion of multi-lead diagnostic capabilities, enhanced focus on continuous heart rhythm monitoring.
The anticipated increase in cases of cardiovascular diseases is expected to drive the growth of the electrocardiograph (ECG) market in the future. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and heart valve problems. ECGs play a crucial role in the diagnosis, treatment, and management of various cardiovascular diseases by enabling doctors to assess the heart's electrical activity and detect abnormalities indicative of heart conditions. Given their essential role in diagnosing heart-related conditions, the demand for electrocardiographs is likely to persist and contribute to market growth. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 years. Consequently, the increasing incidence of cardiovascular diseases is expected to propel the electrocardiograph (ECG) market forward.
Major companies operating in the elastography imaging market are focusing on developing advanced solutions, such as AI-enabled liver elastography systems, to improve diagnostic accuracy, optimize workflows, and enhance patient outcomes. AI-enabled liver elastography systems are sophisticated ultrasound devices that leverage artificial intelligence to assess liver stiffness and detect liver diseases with greater precision and efficiency. For example, in July 2025, AliveCor Inc., a US-based medical device company, launched the Kardia 12L in India, a handheld, AI-powered 12-lead ECG system. It is positioned as the first of its kind with a single-cable, pocket-sized design intended for healthcare professionals and approved by India’s CDSCO regulator. The device features a unique single-cable design, can detect 35 cardiac conditions including arrhythmias and acute myocardial infarction, and is highly portable at 135 grams. Battery-operated and pocket-friendly, it requires minimal training, provides quick non-invasive readings without full patient disrobing, and, with CDSCO approval, significantly enhances access to cardiac diagnostics in India.
In May 2024, WearLinq Inc., a US-based company specializing in wearable health monitoring and diagnostic solutions, acquired AMI Cardiac Monitoring for an undisclosed sum. This acquisition is intended to strengthen WearLinq's cardiac health technology capabilities and expand its product range, facilitating the integration of AMI Cardiac Monitoring's innovative solutions to provide more comprehensive monitoring tools for healthcare providers and patients. AMI Cardiac Monitoring LLC is a US-based medical technology firm that offers remote heart monitoring services.
Major companies operating in the electrocardiograph (ecg) market are Koninklijke Philips N.V., Nihon Kohden Corporation, SCHILLER AG, Fukuda Denshi Co. Ltd., Mindray Bio-Medical Electronics Co. Ltd., Medtronic Plc, General Electric Company, Siemens Healthineers, Spacelabs Healthcare, Mortara Instrument Inc., AliveCor Inc., BPL Medical Technologies, Allengers Medical Systems Limited, Compumedics Limited, Bionet Co. Ltd., Edan Instruments Inc., Norav Medical Ltd., QRS Diagnostic LLC, Biotronik SE & Co. KG, Schwarzer Cardiotek GmbH, Mega Electronics Ltd., Seers Medical.
North America was the largest region in the electrocardiograph (ECG) market in 2025. The regions covered in the electrocardiograph (ecg) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electrocardiograph (ecg) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the electrocardiograph market by increasing the cost of imported electronic components, sensors, semiconductors, and display modules used in portable and stationary ECG systems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported medical electronics, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising device prices and extending procurement cycles. However, they are also encouraging localized manufacturing, regional assembly of ECG systems, and investment in domestic medical device production capabilities.
The electrocardiograph (ecg) market research report is one of a series of new reports that provides electrocardiograph (ecg) market statistics, including electrocardiograph (ecg) industry global market size, regional shares, competitors with a electrocardiograph (ecg) market share, detailed electrocardiograph (ecg) market segments, market trends and opportunities, and any further data you may need to thrive in the electrocardiograph (ecg) industry. This electrocardiograph (ecg) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An electrocardiograph (ECG) is a medical device employed to monitor and record the heart's electrical activity over a period of time. The heart's electrical signals are captured using small metal electrodes positioned on the chest, arms, and legs.
Electrocardiographs (ECG) encompass various products, including holter monitors, resting electrocardiographs (ECG), stress electrocardiographs (ECG), event recorders, and others. Holter monitors are portable ECG devices designed to continuously record the heart's activity for 24 to 48 hours. The technologies involved include portable ECG systems and wireless ECG systems with single-lead, 2-lead, 3-lead, 6-lead, and 12-lead configurations. These systems cater to diverse settings such as hospitals, clinics, homes, ambulatory surgical centers (ASCs), and other end users.
The electrocardiograph market consists of revenues earned by entities by providing patient monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The electrocardiograph market also includes sales of diagnostic ECGs, automatic external defibrillators (AEDs), and ambulatory holter ECG recorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The electrocardiograph (ecg) market size is expected to see strong growth in the next few years. It will grow to $14.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing adoption of home-based cardiac monitoring, rising integration of ai-based ecg analysis, growing demand for continuous patient monitoring, expansion of telecardiology services, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of portable and wearable ecg devices, rising integration of wireless ecg monitoring systems, growing use of remote cardiac monitoring solutions, expansion of multi-lead diagnostic capabilities, enhanced focus on continuous heart rhythm monitoring.
The anticipated increase in cases of cardiovascular diseases is expected to drive the growth of the electrocardiograph (ECG) market in the future. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and heart valve problems. ECGs play a crucial role in the diagnosis, treatment, and management of various cardiovascular diseases by enabling doctors to assess the heart's electrical activity and detect abnormalities indicative of heart conditions. Given their essential role in diagnosing heart-related conditions, the demand for electrocardiographs is likely to persist and contribute to market growth. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 years. Consequently, the increasing incidence of cardiovascular diseases is expected to propel the electrocardiograph (ECG) market forward.
Major companies operating in the elastography imaging market are focusing on developing advanced solutions, such as AI-enabled liver elastography systems, to improve diagnostic accuracy, optimize workflows, and enhance patient outcomes. AI-enabled liver elastography systems are sophisticated ultrasound devices that leverage artificial intelligence to assess liver stiffness and detect liver diseases with greater precision and efficiency. For example, in July 2025, AliveCor Inc., a US-based medical device company, launched the Kardia 12L in India, a handheld, AI-powered 12-lead ECG system. It is positioned as the first of its kind with a single-cable, pocket-sized design intended for healthcare professionals and approved by India’s CDSCO regulator. The device features a unique single-cable design, can detect 35 cardiac conditions including arrhythmias and acute myocardial infarction, and is highly portable at 135 grams. Battery-operated and pocket-friendly, it requires minimal training, provides quick non-invasive readings without full patient disrobing, and, with CDSCO approval, significantly enhances access to cardiac diagnostics in India.
In May 2024, WearLinq Inc., a US-based company specializing in wearable health monitoring and diagnostic solutions, acquired AMI Cardiac Monitoring for an undisclosed sum. This acquisition is intended to strengthen WearLinq's cardiac health technology capabilities and expand its product range, facilitating the integration of AMI Cardiac Monitoring's innovative solutions to provide more comprehensive monitoring tools for healthcare providers and patients. AMI Cardiac Monitoring LLC is a US-based medical technology firm that offers remote heart monitoring services.
Major companies operating in the electrocardiograph (ecg) market are Koninklijke Philips N.V., Nihon Kohden Corporation, SCHILLER AG, Fukuda Denshi Co. Ltd., Mindray Bio-Medical Electronics Co. Ltd., Medtronic Plc, General Electric Company, Siemens Healthineers, Spacelabs Healthcare, Mortara Instrument Inc., AliveCor Inc., BPL Medical Technologies, Allengers Medical Systems Limited, Compumedics Limited, Bionet Co. Ltd., Edan Instruments Inc., Norav Medical Ltd., QRS Diagnostic LLC, Biotronik SE & Co. KG, Schwarzer Cardiotek GmbH, Mega Electronics Ltd., Seers Medical.
North America was the largest region in the electrocardiograph (ECG) market in 2025. The regions covered in the electrocardiograph (ecg) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electrocardiograph (ecg) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the electrocardiograph market by increasing the cost of imported electronic components, sensors, semiconductors, and display modules used in portable and stationary ECG systems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported medical electronics, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising device prices and extending procurement cycles. However, they are also encouraging localized manufacturing, regional assembly of ECG systems, and investment in domestic medical device production capabilities.
The electrocardiograph (ecg) market research report is one of a series of new reports that provides electrocardiograph (ecg) market statistics, including electrocardiograph (ecg) industry global market size, regional shares, competitors with a electrocardiograph (ecg) market share, detailed electrocardiograph (ecg) market segments, market trends and opportunities, and any further data you may need to thrive in the electrocardiograph (ecg) industry. This electrocardiograph (ecg) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An electrocardiograph (ECG) is a medical device employed to monitor and record the heart's electrical activity over a period of time. The heart's electrical signals are captured using small metal electrodes positioned on the chest, arms, and legs.
Electrocardiographs (ECG) encompass various products, including holter monitors, resting electrocardiographs (ECG), stress electrocardiographs (ECG), event recorders, and others. Holter monitors are portable ECG devices designed to continuously record the heart's activity for 24 to 48 hours. The technologies involved include portable ECG systems and wireless ECG systems with single-lead, 2-lead, 3-lead, 6-lead, and 12-lead configurations. These systems cater to diverse settings such as hospitals, clinics, homes, ambulatory surgical centers (ASCs), and other end users.
The electrocardiograph market consists of revenues earned by entities by providing patient monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The electrocardiograph market also includes sales of diagnostic ECGs, automatic external defibrillators (AEDs), and ambulatory holter ECG recorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Electrocardiograph (ECG) Market Characteristics
3. Electrocardiograph (ECG) Market Supply Chain Analysis
4. Global Electrocardiograph (ECG) Market Trends and Strategies
5. Electrocardiograph (ECG) Market Analysis of End Use Industries
7. Global Electrocardiograph (ECG) Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Electrocardiograph (ECG) Total Addressable Market (TAM) Analysis for the Market
9. Electrocardiograph (ECG) Market Segmentation
10. Electrocardiograph (ECG) Market Regional and Country Analysis
11. Asia-Pacific Electrocardiograph (ECG) Market
12. China Electrocardiograph (ECG) Market
13. India Electrocardiograph (ECG) Market
14. Japan Electrocardiograph (ECG) Market
15. Australia Electrocardiograph (ECG) Market
16. Indonesia Electrocardiograph (ECG) Market
17. South Korea Electrocardiograph (ECG) Market
18. Taiwan Electrocardiograph (ECG) Market
19. South East Asia Electrocardiograph (ECG) Market
20. Western Europe Electrocardiograph (ECG) Market
21. UK Electrocardiograph (ECG) Market
22. Germany Electrocardiograph (ECG) Market
23. France Electrocardiograph (ECG) Market
24. Italy Electrocardiograph (ECG) Market
25. Spain Electrocardiograph (ECG) Market
26. Eastern Europe Electrocardiograph (ECG) Market
27. Russia Electrocardiograph (ECG) Market
28. North America Electrocardiograph (ECG) Market
29. USA Electrocardiograph (ECG) Market
30. Canada Electrocardiograph (ECG) Market
31. South America Electrocardiograph (ECG) Market
32. Brazil Electrocardiograph (ECG) Market
33. Middle East Electrocardiograph (ECG) Market
34. Africa Electrocardiograph (ECG) Market
36. Electrocardiograph (ECG) Market Competitive Landscape and Company Profiles
37. Electrocardiograph (ECG) Market Other Major and Innovative Companies
40. Electrocardiograph (ECG) Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Electrocardiograph (ECG) Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses electrocardiograph (ecg) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for electrocardiograph (ecg)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electrocardiograph (ecg) market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Holter Monitors; Resting Electrocardiograph (ECG); Stress Electrocardiograph (ECG); Event Recorders; Other Products2) By Technology: Portable ECG Systems; Wireless ECG Systems
3) By Lead Type: Single Lead ECG; 2 Lead ECG; 3 Lead ECG; 6 Lead ECG; 12-Lead ECG
4) By End User: Hospitals And Clinics; Home Settings And Ambulatory Surgical Centers (ASCs); Other End Users
Subsegments:
1) By Holter Monitors: 24-Hour Holter Monitors; 48-Hour Holter Monitors; 7-Day Holter Monitors2) By Resting Electrocardiograph (ECG): Single-Channel Resting ECG; Multi-Channel Resting ECG
3) By Stress Electrocardiograph (ECG): Treadmill Stress ECG; Pharmacological Stress ECG
4) By Event Recorders: Handheld Event Recorders; Implantable Loop Recorders
5) By Other Products: Mobile ECG Monitors; Telemetry ECG Systems; Accessories
Companies Mentioned: Koninklijke Philips N.V.; Nihon Kohden Corporation; SCHILLER AG; Fukuda Denshi Co. Ltd.; Mindray Bio-Medical Electronics Co. Ltd.; Medtronic Plc; General Electric Company; Siemens Healthineers; Spacelabs Healthcare; Mortara Instrument Inc.; AliveCor Inc.; BPL Medical Technologies; Allengers Medical Systems Limited; Compumedics Limited; Bionet Co. Ltd.; Edan Instruments Inc.; Norav Medical Ltd.; QRS Diagnostic LLC; Biotronik SE & Co. KG; Schwarzer Cardiotek GmbH; Mega Electronics Ltd.; Seers Medical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Electrocardiograph (ECG) market report include:- Koninklijke Philips N.V.
- Nihon Kohden Corporation
- SCHILLER AG
- Fukuda Denshi Co. Ltd.
- Mindray Bio-Medical Electronics Co. Ltd.
- Medtronic Plc
- General Electric Company
- Siemens Healthineers
- Spacelabs Healthcare
- Mortara Instrument Inc.
- AliveCor Inc.
- BPL Medical Technologies
- Allengers Medical Systems Limited
- Compumedics Limited
- Bionet Co. Ltd.
- Edan Instruments Inc.
- Norav Medical Ltd.
- QRS Diagnostic LLC
- Biotronik SE & Co. KG
- Schwarzer Cardiotek GmbH
- Mega Electronics Ltd.
- Seers Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.36 Billion |
| Forecasted Market Value ( USD | $ 14.92 Billion |
| Compound Annual Growth Rate | 9.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
